From Antiretroviral to Antibacterial: Deep-Learning-Accelerated Repurposing and In Vitro Validation of Efavirenz Against Gram-Positive Bacteria
The repurposing potential of Efavirenz (EFV), a clinically established non-nucleoside reverse transcriptase inhibitor, was comprehensively evaluated for its in vitro antibacterial effect either alone or in combination with other antibacterial agents on several Gram-positive clinical strains showing...
Saved in:
Main Authors: | Ezzeldin Saleh, Omar A. Soliman, Nancy Attia, Nouran Rafaat, Daniel Baecker, Mohamed Teleb, Abeer Ghazal, Ahmed Noby Amer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-07-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/30/14/2925 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efavirenz Plasma Concentrations and HIV Viral Load in HIV/AIDS-tuberculosis Infection Patients Treated with Rifampicin
by: Nina Mariana, et al.
Published: (2016-09-01) -
Efavirenz Plasma Concentrations and HIV Viral Load in HIV/AIDS-tuberculosis Infection Patients Treated with Rifampicin
by: Nina Mariana, et al.
Published: (2016-09-01) -
VARIANTS AND PERSPECTIVES OF DRUG REPURPOSING FOR CANCER TREATMENT
by: A. V. Savinkova, et al.
Published: (2018-07-01) -
Study of the Pharmaceutical Grade Polymers effect on the Dissolution of Practically Insoluble Antiretroviral Substances
by: S. A. Zolotov, et al.
Published: (2022-05-01) -
Study of the Technological Methods Effect on Dissolution of the X-ray Amorphous Efavirenz-mesoporous Carrier System
by: S. A. Zolotov, et al.
Published: (2022-09-01)